Section 505(b)(2) Platform for Value Added Medicines
The Platform for Value Added Medicines is an educational association that has provided 5+ years of programming on Value Added Drug development and marketing in the US. The platform has met regularly with FDA and has prominent FDA speakers at their programs. They have also built the largest information base on value added medicines in the US.